Unlock Strategic Intelligence with Fundz

Access exclusive insights on funding rounds, strategic shifts with FundzWatch™, Family Offices, and more — faster than your competitors.

Evolve Immune Therapeutics Holding Company announced it raised $20 Million in an initial filing from an offering of $20 Million

11/01/24, 9:00 PM

Location

branford

Money raised

$20 million

Industry

biotechnology

🔒 Strategic shifts and deeper insights are available for this company. Unlock full access to view hidden updates, executive moves, and more.

Company Info

Company

EvolveImmune Therapeutics

Location

branford, connecticut, united states

Additional Info

EvolveImmune Therapeutics is dedicated to transforming patient outcomes in oncology through its “Immunology First” approach, creating first-in-category cancer medicines that aim to deliver superior, lasting results over current therapies. As pioneers in cancer treatment, EvolveImmune quickly translates scientific discoveries into breakthrough innovations, addressing critical unmet medical needs in cancer with differentiated therapeutic solutions.

Company news

Thu, 31 Oct 2024 07:00:00 GMT

AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics - PR Newswire

Thu, 31 Oct 2024 07:00:00 GMT

AbbVie pays $65M, with $1.4B chaser, for options on EvolveImmune's T-cell engagers - Fierce Biotech

Mon, 13 Jan 2025 08:00:00 GMT

Abbvie and Simcere enter a $1B T-cell engager deal - BioWorld MedTech

Mon, 04 May 2020 14:12:00 GMT

EvolveImmune Therapeutics - Crunchbase

Mon, 11 Dec 2023 08:00:00 GMT

BioCT Names Dr. Stephen Bloch its 2023 Entrepreneur of the Year - Business Wire

Track Every New Funding Round — Before Anyone Else

This is just a small preview. Unlock access to thousands more filtered results — updated in real-time by stage, region, investor & more.

Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.

Related people

Trends

	Raised	Growth The data in the raised column shows reported funding for this location/industry over last 90 days. The data in the growth column indicates the % increase or decrease of the last 90 days vs. the previous 90 days. Please note: one or more large fundings, especially for a location/industry that doesn't historically receive much funding, can have a significant impact on the increase or decrease percentage.
biotechnology	$9.4 B	-20.8%